Safety and Dose Finding Trial of BM32 in Subjects Suffering From Grass Pollen Allergy (Q63321724)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and Dose Finding Trial of BM32 in Subjects Suffering From Grass Pollen Allergy |
clinical trial |
Statements
Safety and Dose Finding Study Based on the Effects of Three Subcutaneous Injections of BM32, a Recombinant Hypoallergenic Grass Pollen Vaccine, on Responses to Allergen Challenge by Skin Testing and in the Vienna Challenge Chamber (VCC) as Well as Immunological Response in Subjects Know to Suffer From Grass-pollen Induced Allergic Rhinitis (English)
0 references
October 2011
0 references
March 2012
0 references
79
0 references
18 year
0 references
60 year
0 references